The ARAHKEY technique: a novel method for the management of access site bleeding during percutaneous transfemoral thoracic aortic endovascular
10.3760/cma.j.cn112434-20230822-00040
- VernacularTitle:ARAHKEY技术在胸主动脉腔内修复术中股动脉穿刺口的管理中的应用
- Author:
Guangrui LIU
1
;
Xiaofeng HAN
;
Tiezheng LI
;
Xiaohai MA
;
Xi GUO
Author Information
1. 首都医科大学附属北京安贞医院介入诊疗科，北京 100029
- Keywords:
Thoracic aorta;
Endovascular repair;
Hemostatic
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(7):406-408
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the safety and effectiveness of ARAHKEY(arterial closure using an additional hemostatic device that is deeply compatible with an extravascular suturing device) technique during percutaneous transluminal repair of thoracic aortic disease(TEVAR).Methods:From January 2021 to January 2023, a total of 202 patients underwent TEVAR in our center.24 patients were treated with ARAHKEY technology, which involves using an additional 7F Exosel at the femoral artery puncture site to achieve hemostatic effect when two ProGlide embedded sutures cannot achieve hemostatic effect.Results:All patients achieved complete hemostasis.The mean time for compression hemostasis was(5.8±2.6)min.In this study cohort, no complications including recurrent bleeding, infection, and late acquired hematoma were observed.Conclusion:ARAHKEY technology is a safe method that can be considered as the primary choice when using ProGlide during TEAVR without achieving hemostatic effects.
